was read the article
array:22 [ "pii" => "S0001731017300091" "issn" => "00017310" "doi" => "10.1016/S0001-7310(17)30009-1" "estado" => "S300" "fechaPublicacion" => "2016-09-01" "aid" => "70044" "copyright" => "Elsevier España, S.L.U. y AEDV" "copyrightAnyo" => "2016" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Actas Dermosifiliogr. 2016;107 Supl 2:51-60" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 94 "formatos" => array:3 [ "EPUB" => 4 "HTML" => 42 "PDF" => 48 ] ] "itemAnterior" => array:18 [ "pii" => "S000173101730008X" "issn" => "00017310" "doi" => "10.1016/S0001-7310(17)30008-X" "estado" => "S300" "fechaPublicacion" => "2016-09-01" "aid" => "70043" "copyright" => "Elsevier España, S.L.U. y AEDV" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Actas Dermosifiliogr. 2016;107 Supl 2:43-50" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 99 "formatos" => array:3 [ "EPUB" => 4 "HTML" => 45 "PDF" => 50 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Experiencia clínica del uso de adalimumab en el manejo de la hidradenitis supurativa. Comparando las tasas de respuesta con la enfermedad de Crohn" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "43" "paginaFinal" => "50" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Clinical experience of the use of adalimumab in the management of hidradenitis suppurativa. Comparison of response rates with Crohn disease" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "B. Moyano, A. Clemente, I. Marín-Jiménez, A. Martorell" "autores" => array:4 [ 0 => array:2 [ "nombre" => "B." "apellidos" => "Moyano" ] 1 => array:2 [ "nombre" => "A." "apellidos" => "Clemente" ] 2 => array:2 [ "nombre" => "I." "apellidos" => "Marín-Jiménez" ] 3 => array:2 [ "nombre" => "A." "apellidos" => "Martorell" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S000173101730008X?idApp=UINPBA000044" "url" => "/00017310/00000107000000S2/v1_201701100052/S000173101730008X/v1_201701100052/es/main.assets" ] "es" => array:11 [ "idiomaDefecto" => true "titulo" => "Aspectos epidemiológicos, clínicos y terapéuticos en situaciones especiales: hidradenitis supurativa infantil" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "51" "paginaFinal" => "60" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "A. Rodríguez Bandera, R. de Lucas Laguna" "autores" => array:2 [ 0 => array:2 [ "nombre" => "A." "apellidos" => "Rodríguez Bandera" ] 1 => array:4 [ "nombre" => "R." "apellidos" => "de Lucas Laguna" "email" => array:1 [ 0 => "rauldelucas@gmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Sección de Dermatología Pediátrica, Hospital Universitario La Paz, Madrid, España" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "*" "correspondencia" => "Autor para correspondencia." ] ] ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Epidemiological, clinical and therapeutic aspects in special situations: hidradenitis suppurativa in paediatric patients" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "PalabrasClave" => array:2 [ "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec785664" "palabras" => array:3 [ 0 => "Hidradenitis supurativa" 1 => "Niños" 2 => "Adolescentes" ] ] ] "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec785663" "palabras" => array:3 [ 0 => "Hidradenitis suppurativa" 1 => "Children" 2 => "Adolescents" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">La hidradenitis supurativa suele aparecer a partir de la tercera década de la vida y es poco frecuente en niños y adolescentes. En este trabajo se revisan los escasos datos epidemiológicos, clínicos y terapéuticos de los que se dispone en este grupo de edad. Desde el punto de vista epidemiológico se han comunicado más casos en niñas, y se ha relacionado con alteraciones hormonales y con una posible mayor carga genética que cuando aparece en adultos. Clínicamente parece que cuando aparece a edades tempranas, la extensión de la enfermedad es mayor. El abordaje terapéutico es especialmente complejo, ya que apenas existe evidencia científica que nos ayude a tomar decisiones. Ayudarles a aceptar la enfermedad, recomendarles hábitos de vida saludables y elegir el tratamiento más adecuado para cada paciente son los retos a los que nos enfrentamos.</p></span>" ] "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Hidradenitis suppurativa usually develops in the third decade of life and is infrequent in children and adolescents. This article reviews the scant epidemiological clinical and therapeutic data that are available for this age group. From the epidemiological point of view, reports have been more numerous in children, which has been related to hormone alterations and with a possibly higher genetic load than when this disease develops in adults. Clinically, it seems that when hidradenitis suppurativa develops in young patients, there is greater disease extension. The therapeutic approach is especially complex, since there is hardly any scientific evidence to serve as a basis for decisions. The challenges posed by this disease are to help patients accept their disease, recommend them healthy lifestyle habits and choose the most appropriate treatment for each patient.</p></span>" ] ] ] "idiomaDefecto" => "es" "url" => "/00017310/00000107000000S2/v1_201701100052/S0001731017300091/v1_201701100052/es/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/00017310/00000107000000S2/v1_201701100052/S0001731017300091/v1_201701100052/es/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017300091?idApp=UINPBA000044" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 16 | 9 | 25 |
2024 October | 135 | 75 | 210 |
2024 September | 124 | 48 | 172 |
2024 August | 203 | 79 | 282 |
2024 July | 121 | 59 | 180 |
2024 June | 122 | 58 | 180 |
2024 May | 136 | 48 | 184 |
2024 April | 104 | 41 | 145 |
2024 March | 91 | 46 | 137 |
2024 February | 124 | 48 | 172 |
2024 January | 105 | 48 | 153 |
2023 December | 80 | 25 | 105 |
2023 November | 82 | 63 | 145 |
2023 October | 81 | 39 | 120 |
2023 September | 94 | 41 | 135 |
2023 August | 82 | 32 | 114 |
2023 July | 95 | 50 | 145 |
2023 June | 90 | 46 | 136 |
2023 May | 85 | 46 | 131 |
2023 April | 62 | 31 | 93 |
2023 March | 80 | 40 | 120 |
2023 February | 53 | 39 | 92 |
2023 January | 44 | 37 | 81 |
2022 December | 39 | 50 | 89 |
2022 November | 70 | 47 | 117 |
2022 October | 66 | 35 | 101 |
2022 September | 62 | 63 | 125 |
2022 August | 54 | 64 | 118 |
2022 July | 73 | 60 | 133 |
2022 June | 61 | 47 | 108 |
2022 May | 60 | 55 | 115 |
2022 April | 40 | 49 | 89 |
2022 March | 85 | 76 | 161 |
2022 February | 51 | 53 | 104 |
2022 January | 35 | 51 | 86 |
2021 December | 28 | 46 | 74 |
2021 November | 35 | 50 | 85 |
2021 October | 48 | 66 | 114 |
2021 September | 28 | 48 | 76 |
2021 August | 33 | 44 | 77 |
2021 July | 32 | 70 | 102 |
2021 June | 22 | 42 | 64 |
2021 May | 42 | 44 | 86 |
2021 April | 61 | 78 | 139 |
2021 March | 41 | 51 | 92 |
2021 February | 43 | 52 | 95 |
2021 January | 30 | 35 | 65 |
2020 December | 26 | 13 | 39 |
2020 November | 34 | 34 | 68 |
2020 October | 32 | 22 | 54 |
2020 September | 28 | 22 | 50 |
2020 August | 37 | 21 | 58 |
2020 July | 15 | 12 | 27 |
2020 June | 36 | 41 | 77 |
2020 May | 26 | 22 | 48 |
2020 April | 20 | 34 | 54 |
2020 March | 17 | 20 | 37 |
2019 November | 1 | 4 | 5 |
2019 September | 1 | 1 | 2 |
2019 June | 0 | 2 | 2 |
2019 May | 0 | 4 | 4 |
2019 April | 0 | 2 | 2 |
2019 February | 0 | 8 | 8 |
2018 November | 2 | 4 | 6 |
2018 September | 1 | 2 | 3 |
2018 August | 1 | 0 | 1 |
2018 June | 0 | 1 | 1 |
2018 April | 0 | 1 | 1 |
2018 February | 4 | 1 | 5 |
2018 January | 3 | 0 | 3 |
2017 December | 3 | 0 | 3 |
2017 November | 5 | 1 | 6 |
2017 October | 1 | 1 | 2 |
2017 September | 3 | 1 | 4 |
2017 August | 1 | 1 | 2 |
2017 July | 2 | 1 | 3 |
2017 June | 5 | 0 | 5 |
2017 May | 2 | 1 | 3 |
2017 April | 3 | 1 | 4 |
2017 March | 0 | 4 | 4 |
2017 February | 3 | 2 | 5 |
2017 January | 1 | 5 | 6 |